MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA

被引:40
作者
Li, Chao [1 ]
Zhu, Hua-Yu [1 ]
Bai, Wen-Dong [2 ]
Su, Lin-Lin [1 ]
Liu, Jia-Qi [1 ]
Cai, Wei-Xia [1 ]
Zhao, Bin [1 ]
Gao, Jian-Xin [1 ]
Han, Shi-Chao [1 ]
Li, Jun [1 ]
Hu, Da-Hai [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shanxi, Peoples R China
[2] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shanxi, Peoples R China
基金
中国博士后科学基金;
关键词
MicroRNA; Hypertrophic scar; Collagen type 1; Urokinase type plasminogen activator; Plasminogen activator inhibitor-1; PLASMINOGEN-ACTIVATOR INHIBITOR-1; DIFFERENTIAL EXPRESSION; LIVER FIBROSIS; III COLLAGEN; MOUSE SKIN; UROKINASE; FIBROBLASTS; MICRORNAS; GROWTH; MIGRATION;
D O I
10.1016/j.febslet.2014.12.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urokinase type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) have been proposed to play key roles in extracellular matrix (ECM) deposition in hypertrophic scars (HS). Here, we found that in HS fibroblasts (HFs) miR-181c and miR-10a were differentiallyexpressed and targeted uPA and PAI-1, respectively. The production of Type 1 collagen (Col1) was inhibited by miR-181c knockdown or miR-10a overexpression in HFs, and this resulted in increased levels of metalloproteinase 1 (MMP1). These results suggest that the miR-181c-uPA and miR-10a-PAI-1 regulatory pathways have an integral role in HS pathogenesis. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:380 / 389
页数:10
相关论文
共 45 条
[1]   siRNA Knockdown of Tissue Inhibitor of Metalloproteinase-1 in Keloid Fibroblasts Leads to Degradation of Collagen Type I [J].
Aoki, Masayo ;
Miyake, Koichi ;
Ogawa, Rei ;
Dohi, Teruyuki ;
Akaishi, Satoshi ;
Hyakusoku, Hiko ;
Shimada, Takashi .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (03) :818-826
[2]   SYNERGISTIC ENHANCEMENT OF TYPE-I AND TYPE-III COLLAGEN PRODUCTION IN CULTURED FIBROBLASTS BY TRANSFORMING GROWTH FACTOR-BETA AND ASCORBATE [J].
APPLING, WD ;
OBRIEN, WR ;
JOHNSTON, DA ;
DUVIC, M .
FEBS LETTERS, 1989, 250 (02) :541-544
[3]   Long-term organ culture of keloid disease tissue [J].
Bagabir, Rania ;
Syed, Farhatullah ;
Paus, Ralf ;
Bayat, Ardeshir .
EXPERIMENTAL DERMATOLOGY, 2012, 21 (05) :376-381
[4]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS [J].
BOUCHET, C ;
SPYRATOS, F ;
MARTIN, PM ;
HACENE, K ;
GENTILE, A ;
OGLOBINE, J .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :398-405
[7]   What Goes Up Must Come Down: The Emerging Role of MicroRNA in Fibrosis [J].
Chau, B. Nelson ;
Brenner, David A. .
HEPATOLOGY, 2011, 53 (01) :4-6
[8]   miRNA expression profile in primary gastric cancers and paired lymplh node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes [J].
Chen, Weidong ;
Tang, Zhaoqing ;
Sun, Yihong ;
Zhang, Youyou ;
Wang, Xuefei ;
Shen, Zhenbin ;
Liu, Fenglin ;
Qin, Xinyu .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (02) :351-356
[9]   PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor [J].
Degryse, B ;
Sier, CFM ;
Resnati, M ;
Conese, M ;
Blasi, F .
FEBS LETTERS, 2001, 505 (02) :249-254
[10]   Plasminogen Activator Inhibitor-1 Controls Bone Marrow-Derived Cells Therapeutic Effect Through MMP9 Signaling: Role in Physiological and Pathological Wound Healing [J].
Ebrahimian, Teni G. ;
Squiban, Claire ;
Roque, Telma ;
Lugo-Martinez, Haydee ;
Hneino, Mohamad ;
Buard, Valerie ;
Gourmelon, Patrick ;
Benderitter, Marc ;
Milliat, Fabien ;
Tamarat, Radia .
STEM CELLS, 2012, 30 (07) :1436-1446